MacroGenics
Developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases. Learn more
Launch date
Employees
Market cap
€211m
Enterprise valuation
€114m (Public information from Sep 2024)
Share price
$3.3 MGNX
Rockville Maryland (HQ)
Authorizing premium user...